Centofanti Marco

Parisi Vincenzo, Centofanti Marco, Ziccardi Lucia, Tanga Lucia, Michelessi Manuele, Roberti Gloria et al.

Citicoline eye drops improved retinal function and visual pathway conduction in glaucoma patients, suggesting potential neuroprotection.

Digiuni Maurizio, Manni Gianluca, Vetrugno Michele, Uva Maurizio, Milano Giovanni, Orzalesi Nicola et al.

This study found generic 0.005% latanoprost is noninferior to brand Xalatan in lowering IOP for glaucoma/ocular hypertension, offering an equally effective and well-tolerated treatment option.

Iester Michele, Oddone Francesco, Prato Mirko, Centofanti Marco, Fogagnolo Paolo, Rossetti Luca et al.

This study developed new formulas using HRT3 parameters to improve Glaucoma Probability Score (GPS) detection. These formulas, especially one incorporating sectorial rim area, significantly enhanced glaucoma diagnostic accuracy.

Parisi Vincenzo, Ziccardi Lucia, Centofanti Marco, Tanga Lucia, Gallinaro Geltrude, Falsini Benedetto et al.

MfERG revealed macular dysfunction (reduced amplitude, delayed timing) in glaucoma patients, correlating with visual field loss, suggesting early damage to preganglionic retinal cells.

Saccà Sergio Claudio, Centofanti Marco, Izzotti Alberto

This study found 13 proteins, linked to inflammation, lipid transport, muscle function, stress, and signaling, were elevated in glaucoma patients' aqueous humor, reflecting anterior chamber damage.

Oddone Francesco, Centofanti Marco, Tanga Lucia, Parravano Mariacristina, Michelessi Manuele, Schiavone Mauro et al.

This study found optic disc size significantly impacts HRT3 glaucoma diagnosis, but not OCT or GDx RNFL assessments, suggesting OCT/GDx provide more consistent diagnostic accuracy across varying disc sizes.

Tanga Lucia, Centofanti Marco, Oddone Francesco, Parravano Mariacristina, Parisi Vincenzo, Ziccardi Lucia et al.

This study found hydroxychloroquine patients without toxicity signs had significantly reduced retinal function via frequency-doubling perimetry, suggesting its utility for early detection of drug-induced retinal damage.

Tranchina Laura, Centofanti Marco, Oddone Francesco, Tanga Lucia, Roberti Gloria, Liberatoscioli Laura et al.

This study found plasma homocysteine is significantly higher in pseudoexfoliation glaucoma (PEXG) than other glaucoma types or controls, suggesting it may be a modifiable risk factor for PEXG.

Fogagnolo Paolo, Sangermani Chiara, Oddone Francesco, Frezzotti Paolo, Iester Michele, Figus Michele et al.

This study found visual field fluctuation peaks in moderate-severe glaucoma (GSS2 stage 4), decreasing in early/late stages. Clinically, understanding this variability helps differentiate true progression from normal test-retest changes.

Fogagnolo Paolo, Tanga Lucia, Rossetti Luca, Oddone Francesco, Manni Gianluca, Orzalesi Nicola et al.

This study found SITA SWAP in ocular hypertension patients has a mild learning effect, mainly on foveal sensitivity in the first test. This supports its clinical utility for early glaucoma diagnosis.

Centofanti Marco, Oddone Francesco, Gandolfi Stefano, Hommer Anton, Boehm Andreas, Tanga Lucia et al.

This study found bimatoprost/timolol lowered IOP more than travoprost/timolol in glaucoma patients inadequately controlled by latanoprost/timolol, offering a more potent alternative.

Oddone Francesco, Centofanti Marco, Iester Michele, Rossetti Luca, Fogagnolo Paolo, Michelessi Manuele et al.

HRT3 sectorial analysis was studied for glaucoma diagnosis. It improved accuracy, especially inferotemporally/inferonasally, varying with disc size, suggesting clinical utility over global analysis.

Centofanti Marco, Fogagnolo Paolo, Oddone Francesco, Orzalesi Nicola, Vetrugno Michele, Manni Gianluca et al.

This study found a mild learning effect for Humphrey Matrix FDT perimetry's mean defect and foveal sensitivity, impacting only the first test in ocular hypertension patients. Retesting may be advisable.

Oddone Francesco, Centofanti Marco, Rossetti Luca, Iester Michele, Fogagnolo Paolo, Capris Elisabetta et al.

This study found HRT3's RB-LDF and CSM algorithms offer the most consistent glaucoma diagnostic accuracy across varying optic disc sizes and disease stages, outperforming MRA and GPS.

Rossetti Luca, Karabatsas Costas H, Topouzis Fotis, Vetrugno Michele, Centofanti Marco, Boehm Andreas et al.

This study compared bimatoprost and latanoprost-timolol fixed combination on 24-hour IOP. Bimatoprost was non-inferior to LTFC in maintaining controlled IOP, suggesting it's a viable alternative for patients switching from non-fixed combinations.

Fogagnolo Paolo, McNaught Andrew, Centofanti Marco, Rossetti Luca, Orzalesi Nicola

This study found trabeculectomy, but not medical therapy, significantly reduced long-term visual field variability in glaucoma patients. This suggests better visual field stability after surgery.

Rossetti Luca, Fogagnolo Paolo, Miglior Stefano, Centofanti Marco, Vetrugno Michele, Orzalesi Nicola

SWAP testing in ocular hypertensives shows a significant learning effect, especially peripherally. This impacts early glaucoma detection and normative data development, requiring careful consideration.

Parisi Vincenzo, Miglior Stefano, Manni Gianluca, Centofanti Marco, Bucci Massimo G

PERG/VEP testing detected early retinal/optic nerve dysfunction in most ocular hypertension patients, even with normal standard tests, and correlated with visual field loss in glaucoma, offering potential for earlier detection.

Manni Gianluca, Centofanti Marco, Oddone Francesco, Parravano Mariacristina, Bucci Massimo G

This study found preserved beta-blocker eye drops significantly increase tear inflammatory markers (IL-1beta) and reduce tear film stability in glaucoma patients, suggesting preservative-free options are better for long-term use.

Manni Gianluca, Centofanti Marco, Parravano Mariacristina, Oddone Francesco, Bucci Massimo G

This study found bimatoprost and latanoprost/timolol combination equally lowered IOP in glaucoma patients, but the combination had fewer ocular side effects, guiding treatment choices.

Manni Gianluca, Centofanti Marco, Sacchetti Marta, Oddone Francesco, Bonini Stefano, Parravano Mariacristina et al.

This study found patients with prior eye-drop allergies or reduced tear production are more prone to brimonidine 0.2% ocular allergy, aiding risk assessment.